Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Raymond Vanholder, MD, PhD
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 5 ans
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
Comparison of the efficacy of dialysis by conventional dialysis versus Prometheus artificial hepatic system
Country
Belgium
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis
Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients with lactate acidosis. The sampling of blood and dialy...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 5 ans
Uremic Toxins of Patients With Acute Kidney Failure
Determination of the concentration of uremic toxins of sepsis patients with or without acute kidney failure compared to the concentrations of uremic toxins of chronically uremic patients
Country
Belgium
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
The purpose of this study is to determine the prevalence of Fabry mutations in patients with left ventricular hypertrophy (moderate to severe), as measured by echocardiography.This study i...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 5 ans
Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study
This study is an open, randomised trial in which one group of patients (control) will receive the golden standard therapy and the other group (treatment) will receive individually adapted ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP. The medical file is gathered. There will be searched...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 5 ans
Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Atypical hemolytic uraemic syndrome is caused by defects in the regulating factors in the alternative pathway of the complement system. Triggering can cause an uncontrolled complement acti...
Country
Belgium
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis
This is a prospective cross-over study including 10 stable hemodialysis patients with chronic kidney disease stage 5. The cross-over study lasts 2 weeks with the study dialysis sessions at...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Uremic Toxins in the ICU: Patients After Cardiac Surgery
Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients after cardiac surgery.The sampling of blood and dialys...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 5 ans
Peritoneal Dialysis Versus Haemodialysis
Study in order to quantify toxin removal during dialysis
Country
Belgium
organs
None
Specialty
None
unknown
More information
1
2
Next